GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Other Long-Term Liabilities

Oncodesign Precision Medicine (XPAR:ALOPM) Other Long-Term Liabilities : €0.03 Mil (As of Jun. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Other Long-Term Liabilities?

Oncodesign Precision Medicine's other long-term liabilities for the quarter that ended in Jun. 2022 was €0.03 Mil.

Oncodesign Precision Medicine's quarterly other long-term liabilities declined from Dec. 2020 (€0.19 Mil) to Dec. 2021 (€0.06 Mil) and declined from Dec. 2021 (€0.06 Mil) to Jun. 2022 (€0.03 Mil).

Oncodesign Precision Medicine's annual other long-term liabilities increased from . 20 (€0.00 Mil) to Dec. 2020 (€0.19 Mil) but then declined from Dec. 2020 (€0.19 Mil) to Dec. 2021 (€0.06 Mil).

Oncodesign Precision Medicine Other Long-Term Liabilities Historical Data

The historical data trend for Oncodesign Precision Medicine's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Other Long-Term Liabilities Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Other Long-Term Liabilities
- -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Other Long-Term Liabilities - - -

Oncodesign Precision Medicine Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Oncodesign Precision Medicine Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Other Long-Term Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Website
https://www.opm.oncodesign.com
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines